title: Synthesis and structure-activity relationships of oxamic acid and acetic acid derivatives related to L-thyronine.
abstract: Aryloxamic acids 7 and 23, (arylamino)acetic acids 29, arylpropionic acids 33, arylthioacetic acids 37, and (aryloxy)acetic acid 41 related to L-triiodothyronine (L-T3) were prepared and tested in vitro for binding to the rat liver nuclear L-T3 receptor and the rat membrane L-T3 receptor. The structure-activity relationships for these compounds are described, with 7f, 23a, 29c, 33a, 37b, and 41 showing excellent potency (IC50's of 0.19, 0.16, 1.1, 0.11, 3.5, and 0.10 nM, respectively) to the nuclear receptor and significantly lower binding affinity to the membrane receptor (IC50's > 5 microM). Some of these compounds, especially in the oxamic acid series 7 and 23, showed an unprecedented potency for methyl-substituted derivatives such as 7f and 23a. Compounds 7f and 23a showed good lipid lowering effects in rats with ED50's of 20 and 5 micrograms/kg po, respectively, and a lack of cardiac side effects in rats at doses as high as 10 and 25 mg/kg po, respectively.
authors.affiliation: Research Department, Ciba Pharmaceuticals, Summit, New Jersey 07901.
authors.forename: N
authors.initials: N
authors.lastname: Yokoyama
authors.forename: G N
authors.initials: GN
authors.lastname: Walker
authors.forename: A J
authors.initials: AJ
authors.lastname: Main
authors.forename: J L
authors.initials: JL
authors.lastname: Stanton
authors.forename: M M
authors.initials: MM
authors.lastname: Morrissey
authors.forename: C
authors.initials: C
authors.lastname: Boehm
authors.forename: A
authors.initials: A
authors.lastname: Engle
authors.forename: A D
authors.initials: AD
authors.lastname: Neubert
authors.forename: J M
authors.initials: JM
authors.lastname: Wasvary
authors.forename: Z F
authors.initials: ZF
authors.lastname: Stephan
mesh_terms: D000085:Acetates / Q000737:chemistry* / Q000494:pharmacology; D019342:Acetic Acid; D000818:Animals; D000960:Hypolipidemic Agents / Q000138:chemical synthesis / Q000737:chemistry* / Q000494:pharmacology; D008099:Liver / Q000187:drug effects / Q000378:metabolism; D008297:Male; D009200:Myocardial Contraction / Q000187:drug effects; D010072:Oxamic Acid / Q000031:analogs & derivatives / Q000737:chemistry* / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley; D011956:Receptors, Cell Surface / Q000187:drug effects / Q000378:metabolism; D018160:Receptors, Cytoplasmic and Nuclear / Q000187:drug effects / Q000378:metabolism; D013329:Structure-Activity Relationship; D013970:Thyronines / Q000737:chemistry*
chemical_list: D000085:Acetates; D000960:Hypolipidemic Agents; D011956:Receptors, Cell Surface; D018160:Receptors, Cytoplasmic and Nuclear; D013970:Thyronines; D019342:Acetic Acid; D010072:Oxamic Acid